Publicité
Publicité

GRI

GRI logo

GRI Bio, Inc. Common Stock

0.23
USD
Sponsorisé
-0.06
-20.77%
09 janv., 15:57 UTC -5
Fermé
exchange

Après-marché

0.22

0.00
-1.78%

GRI Rapports sur les bénéfices

Ratio de surprise positive

GRI a dépassé 4 des 8 dernières estimations.

50%

Prochain rapport

Date du prochain rapport
12 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.05
Variation implicite de Q3 25 (Revenue/ EPS)
--
/
-17.97%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/
+5150.00%

GRI Bio, Inc. Common Stock earnings per share and revenue

On 14 nov. 2025, GRI reported earnings of -1.28 USD per share (EPS) for Q3 25, missing the estimate of -0.93 USD, resulting in a -36.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -1.05 USD, with revenue projected to reach -- USD, implying an baisse of -17.97% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, GRI Bio, Inc. Common Stock reported EPS of -$1.28, missing estimates by -36.27%, and revenue of $0.00, 0% as expectations.
The stock price moved -- 0%, changed from $1.69 before the earnings release to $1.69 the day after.
The next earning report is scheduled for 12 mars 2026.
Based on 3 analystes, GRI Bio, Inc. Common Stock is expected to report EPS of -$1.05 and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité